These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7690921)

  • 1. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
    Tangtakul S; Srisupundit S
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
    [No Abstract]   [Full Text] [Related]  

  • 6. Molar pregnancy with false negative urine hCG: the hook effect.
    Pang YP; Rajesh H; Tan LK
    Singapore Med J; 2010 Mar; 51(3):e58-61. PubMed ID: 20428735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hook effect as a cause of falsely lowered beta-HCG values].
    Dahlmann N
    Dtsch Med Wochenschr; 1989 Jan; 114(1):36-7. PubMed ID: 2463141
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian choriocarcinoma: a difficult diagnosis of an unusual tumor and a review of the hook effect.
    Wheeler CA; Davis S; Degefu S; Thorneycroft IH; O'Quinn AG
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):547-9. PubMed ID: 1689478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.